Insider trading

Period: 120 months Stock: QURE + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

272 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

272 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

272 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

272 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
272 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
272 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

272 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
28 Jan 2019
McMillan Scott T. Chief Operating Officer
Sold, plan not stated
$18.46K 591 at 31.23
2.8%
17 Jan 2019
SCHAFFER DAVID Director
Sold, plan not stated
$230.33K 7,500 at 30.71
14.6%
3 Jan 2019
KLEMT CHRISTIAN Chief Accounting Officer
Sold, plan not stated
$160.18K 5,739 at 27.91
12.5%
3 Dec 2018
Sold, plan not stated
$151.95K 5,000 at 30.39
17.7%
6 Jun 2018
Zelenkofske Steven Chief Medical Officer
Sold, plan not stated
$888.72K 23,929 at 37.14
13.0%
15 Mar 2018
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated
$850.75K 39,169 at 21.72
8.2%
29 Jan 2018
Sold, plan not stated
$121.19K 6,540 at 18.53
18.8%
29 Jan 2018
van Deventer Sander Chief Scientific Officer · indirect
Sold, plan not stated
$110.90K 5,985 at 18.53
19.3%
29 Jan 2018
Sold, plan not stated
$53.33K 2,878 at 18.53
13.8%
29 Jan 2018
Kaye Jack Director
Sold, plan not stated
$53.33K 2,878 at 18.53
18.2%
29 Jan 2018
SCHAFFER DAVID Director
Sold, plan not stated
$53.33K 2,878 at 18.53
15.8%
4 Jan 2018
Kapusta Matthew C CEO, CFO, Managing Director
Sold, plan not stated
$431.07K 21,690 at 19.87
4.6%
3 Jan 2018
Garen Jonathan Chief Business Officer
Sold, plan not stated
$118.03K 5,864 at 20.13
6.4%
3 Jan 2018
Firuta Paul E Chief Commercial Officer
Sold, plan not stated
$118.03K 5,864 at 20.13
6.4%
3 Jan 2018
Cantor Maria E SVP, Investor Relations & Comm
Sold, plan not stated
$118.03K 5,864 at 20.13
6.4%
3 Jan 2018
KLEMT CHRISTIAN Chief Accounting Officer
Sold, plan not stated
$102.51K 5,093 at 20.13
12.0%
29 Jun 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$129.71K 21,547 at 6.02
100%
Sold half or more
28 Jun 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$166.86K 27,753 at 6.01
100%
Sold half or more
27 Jun 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$46.22K 7,700 at 6.00
100%
Sold half or more
26 Jun 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$349.05K 58,075 at 6.01
100%
Sold half or more
22 Jun 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$930.00 155 at 6.00
100%
Sold half or more
21 Mar 2017
Petry Harald Chief Scientific Officer
Sold, plan not stated
$153.29K 25,422 at 6.03
100%
Sold half or more
Showing 251–272 of 272. ← Newer Page 6 of 6